Preparation and characterization of novel as-cast Ti-Mo-Nb alloys for biomedical applications

被引:0
作者
Giovana Collombaro Cardoso
Gerson Santos de Almeida
Dante Oliver Guim Corrêa
Willian Fernando Zambuzzi
Marília Afonso Rabelo Buzalaf
Diego Rafael Nespeque Correa
Carlos Roberto Grandini
机构
[1] UNESP - Univ Estadual Paulista,Laboratório de Anelasticidade e Biomateriais
[2] IBTN-Br – Institute of Biomaterials,Instituto de Biociências
[3] Tribocorrosion and Nanomedicine – Brazilian Branch,Bauru School of Dentistry
[4] ,undefined
[5] UNESP - Univ Estadual Paulista,undefined
[6] University of São Paulo,undefined
[7] IFSP – Federal Institute of Education,undefined
[8] Science and Technology of São Paulo,undefined
来源
Scientific Reports | / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Ti and its alloys are the most used metallic biomaterials devices due to their excellent combination of chemical and mechanical properties, biocompatibility, and non-toxicity to the human body. However, the current alloys available still have several issues, such as cytotoxicity of Al and V and high elastic modulus values, compared to human bone. β-type alloys, compared to α-type and (α + β)-type Ti alloys, have lower elastic modulus and higher mechanical strength. Then, new biomedical β-type alloys are being developed with non-cytotoxic alloying elements, such as Mo and Nb. Therefore, Ti-5Mo-xNb system alloys were prepared by argon arc melting. Chemical composition was evaluated by EDS analysis, and the density measurements were performed by Archimedes' method. The structure and microstructure of the alloys were obtained by X-ray diffraction and optical and scanning electron microscopy. Microhardness values were analyzed, and MTT and crystal violet tests were performed to assess their cytotoxicity. As the Nb concentration increases, the presence of the β-Ti phase also grows, with the Ti-5Mo-30Nb alloy presenting a single β-Ti phase. In contrast, the microhardness of the alloys decreases with the addition of Nb, except the Ti-5Mo-10Nb alloy, which has its microhardness increased probably due to the ω phase precipitation. Biological in-vitro tests showed that the alloys are not cytotoxic.
引用
收藏
相关论文
共 98 条
  • [1] Xu LJ(2008)The microstructure and properties of Ti–Mo–Nb alloys for biomedical application J. Alloy. Compd. 453 320-324
  • [2] Chen YY(2019)Microstructure, phase composition and mechanical properties of new, low cost Ti-Mn-Nb alloys for biomedical applications J. Alloy. Compd. 787 570-577
  • [3] Liu ZG(1998)Mechanical properties of biomedical titanium alloys Mater. Sci. Eng. A 243 231-236
  • [4] Kong FT(2004)Study of nontoxic aluminum and vanadium-free titanium alloys for biomedical applications Mater. Sci. Eng. C 24 679-682
  • [5] Ehtemam-Haghighi S(2004)Biocompatibility of β-stabilizing elements of titanium alloys Biomaterials 25 5705-5713
  • [6] Attar H(2010)Cytotoxicity of titanium and titanium alloying elements J. Dent. Res. 89 493-497
  • [7] Dargusch MS(2012)Effects of molybdenum content on the structure and mechanical properties of as-cast Ti–10Zr-based alloys for biomedical applications Mater. Sci. Eng. C 32 517-522
  • [8] Kent D(2011)Preparation and characterization of Ti-15Mo alloy used as biomaterial Mater. Res. 14 107-112
  • [9] Niinomi M(2020)Development of novel Ti-Mo-Mn alloys for biomedical applications Sci. Rep. 10 6298-2869
  • [10] Silva HM(2002)Evaluation of the TiMo12Zr6Fe2 alloy for orthopaedic implants: In vitro biocompatibility study by using primary human fibroblasts and osteoblasts Biomaterials 23 2863-1997